S. 1056 · 110th Congress
National Cancer Act of 2007
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 110th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
FeinsteinSponsor1 cosponsor · 1 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
National Cancer Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to establish a loan repayment program for health professionals agreeing to engage in cancer prevention research.
What it does: CRS summary · Introduced in Senate · Mar 29, 2007
National Cancer Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to establish a loan repayment program for health professionals agreeing to engage in cancer prevention research.
Provides for research on cancer treatments that target cancer cells, the cancer care workforce, cancer survivorship, environmental risk factors for cancer, and treatment disparities.
Requires the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out demonstration programs on: (1) lung cancer early detection using Computer Tomography (CT) scanning; and (2) colorectal screening.
Amends the Federal Food, Drug, and Cosmetic Act to set forth provisions for chemoprevention drugs that: (1) allow the Secretary to designate such drugs; and (2) provide market exclusivity for seven years for approved drugs or licensed biological products. Defines "chemoprevention drug" as a drug designed to treat a high-risk medical condition that: (1) has been diagnosed in individuals who have not been diagnosed with cancer or who do not currently have progressive, life-threatening cancer; and (2) unless treated, could develop into progressive and life-threatening cancer.
Establishes the ChemoPrevention Products Board to develop chemoprevention drugs and devices.
Requires the Secretary to establish a program to expand access to investigational treatments for individuals diagnosed with cancer.
Amends title XVIII (Medicare) of the Social Security Act to provide coverage for cancer care coordinators who provide overall coordination and management of the medical, nursing, and other health services provided to individuals diagnosed with cancer.
Allows a biorepository to adopt specified guidelines for the collection of biospecimens. Requires the Medicare Payment Assessment Commission (MedPAC) to report to Congress on developing a payment system for collecting and storing cancer tissue for research.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: National Cancer Act of 2007
Latest action (Mar 29, 2007): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Mar 29, 2007
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.